The role of opioid receptors in modulating Alzheimer's Disease
Alzheimer's disease (AD) is a complex neurological disorder characterized by accumulation of amyloid plaques and neurofibrillary tangles. Long term investigation of AD pathogenesis suggests that β-site amyloid precursor protein [APP] cleaving enzyme 1 (BACE1) and γ-secretase enzymes promote the...
Saved in:
Main Authors: | Parthasaradhireddy Tanguturi (Author), John M. Streicher (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer's Disease
by: Pontus Forsell, et al.
Published: (2024) -
Drug-induced gingival overgrowth: A critical insight into case reports from over two decades
by: Pramod Samudrala, et al.
Published: (2016) -
Enhancing pharmacovigilance for robust drug safety monitoring: addressing underreporting and collaborative solutions
by: Tanguturi Yella Sree Sudha, et al.
Published: (2024) -
Exploring the Role of P2X Receptors in Alzheimer's Disease
by: Pamela Andrea Godoy, et al.
Published: (2019) -
Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
by: Muzeyyen Ugur, et al.
Published: (2018)